ID: ALA298425

Max Phase: Preclinical

Molecular Formula: C7H10O6

Molecular Weight: 190.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC1=C(O)C(=O)OC1C(O)CO

Standard InChI:  InChI=1S/C7H10O6/c1-12-6-4(10)7(11)13-5(6)3(9)2-8/h3,5,8-10H,2H2,1H3

Standard InChI Key:  HFSCYDMAVALOIA-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-amylase 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 190.15Molecular Weight (Monoisotopic): 190.0477AlogP: -1.32#Rotatable Bonds: 3
Polar Surface Area: 96.22Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.11CX Basic pKa: CX LogP: -1.80CX LogD: -1.88
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.48Np Likeness Score: 2.02

References

1. Abell AD, Ratcliffe MJ, Gerrard J..  (1998)  Ascorbic acid-based inhibitors of alpha-amylases.,  (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4]

Source